Human albumin solution for on-pump cardiac surgery: benefit or burden? Author’s reply
Authors:
- Geoffrey J. WigmoreGWGeoffrey J. Wigmore
- Adam M. DeaneADAdam M. Deane
- Jeffrey J. PresneillJPJeffrey J. Presneill
- Rinaldo BellomoRBRinaldo Bellomo
- the HAS FLAIR-II investigatorsTIthe HAS FLAIR-II investigators
- 16 September 2024
- journal article
- letter
- Published by Springer Nature in Intensive Care Medicine
- Vol. 50 (11) , 1947-1948
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Human albumin solution for on-pump cardiac surgery: benefit or burden?Intensive Care Medicine, 2024
- Twenty percent human albumin solution fluid bolus administration therapy in patients after cardiac surgery-II: a multicentre randomised controlled trialIntensive Care Medicine, 2024
- HAS FLAIR Investigators Reply to Fluid Resuscitation After Cardiac Surgery: The Quest for the Ideal FluidJournal of Cardiothoracic and Vascular Anesthesia, 2019
- 20% Human Albumin Solution Fluid Bolus Administration Therapy in Patients After Cardiac Surgery (the HAS FLAIR Study)Journal of Cardiothoracic and Vascular Anesthesia, 2019
- Principles of fluid management and stewardship in septic shock: it is time to consider the four D’s and the four phases of fluid therapyAnnals of Intensive Care, 2018